Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02291302 · ClinicalTrials.gov registry record · NA

School Inner-City Asthma Intervention Study (SICAS-2)

A NA study, sponsored by Boston Children's Hospital.

Completed
Registry status
NA
Development phase
236
Enrollment target

NCT02291302: Completed NA study, sponsored by Boston Children's Hospital.

NCT02291302 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 236 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02291302, a NA study, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
NA
Development phase
236 participants
Enrollment target

Study Summary

The investigators goal is to determine the efficacy of school/classroom based environmental intervention in reducing asthma morbidity in urban schoolchildren.

Primary Outcome

Maximum number of 1. Days with wheezing, tightness in the chest, or cough and/or 2. Nights with disturbed sleep as a result of asthma and/or 3. Days on which the child had to slow down or discontinue play activities because of asthma This is defined as a cumulative assessment from the different variables listed in the Measure Description

Interventions

  • OTHER integrated pest management
  • OTHER air purifier
  • OTHER No intervention (control)

Trial Details

FieldValue
Enrollment Target 236 participants
Start Date 2015-01
Est. Completion 2020-06
Phase NA
Boston Children's Hospital

462 total trials

What the finished NCT02291302 record still lists

NCT02291302 is an interventional study that assigns participants to a tested intervention. The registered 236 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 3 interventions - of which integrated pest management is the first listed.

NCT02291302 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02291302 about?

NCT02291302 is a clinical study titled "School Inner-City Asthma Intervention Study (SICAS-2)". The investigators goal is to determine the efficacy of school/classroom based environmental intervention in reducing asthma morbidity in urban schoolchildren.

What is the current status of trial NCT02291302?

This trial is currently completed. It is a NA study. The enrollment target is 236 participants. The study started on 2015-01. Estimated completion is 2020-06.

What interventions are being tested in trial NCT02291302?

The interventions under investigation include: integrated pest management (OTHER), air purifier (OTHER), No intervention (control) (OTHER).

Who is sponsoring clinical trial NCT02291302?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02291302's enrollment target sits among peer trials

236 461st of 2000 higher than 1,540 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04995341 · 236 participants · NA

    Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)

  • NCT05822362 · 236 participants · Phase 2

    CBD for Individuals at Risk for Alzheimer's Disease

  • NCT06200103 · 236 participants · Phase 2

    Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

  • NCT06494072 · 236 participants · Phase 4

    Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02291302, the US trial registry maintained by the National Library of Medicine. NCT02291302 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.